The characteristics of relapse in adult-onset minimal-change nephrotic syndrome

被引：32

作者：

Takei T. ^{[1
]}

Koike M. ^{[1
]}

Suzuki K. ^{[1
]}

Shirota S. ^{[1
]}

Itabashi M. ^{[1
]}

Ohtsubo S. ^{[1
]}

Sugiura H. ^{[1
]}

Suzuki K. ^{[1
]}

Kojima C. ^{[1
]}

Takahashi M. ^{[1
]}

Ino J. ^{[1
]}

Ogawa T. ^{[1
]}

Uchida K. ^{[1
]}

Tsuchiya K. ^{[1
]}

Yumura W. ^{[1
]}

Nitta K. ^{[1
]}

机构：

[1] Department of Medicine, Kidney Center, Tokyo Women's Medical University, Shinjuku-ku, Tokyo 162-8666

来源：

Clinical and Experimental Nephrology | 2007年 / 11卷 / 3期

关键词：

Immunoglobulin E (IgE); Minimal-change nephrotic syndrome (MCNS); Relapse; Steroid side effects;

D O I：

10.1007/s10157-007-0484-5

中图分类号：

学科分类号：

摘要：

Background. Although minimal-change nephrotic syndrome (MCNS) is highly steroid-responsive, the frequency of relapses in some patients is high, necessitating the administration of repeated courses of prednisolone in high doses. It is, therefore, necessary to identify factors that can predict this increased risk of relapse in some patients in order to establish useful treatment methods to reduce the risk. Methods. To clarify the factors that might increase the risk of relapses, the data of 82 Japanese adult patients with MCNS receiving treatment at our department were analyzed retrospectively. Of the total, 55 patients (67.1%) experienced relapse after showing an initial response. We divided the patients into two groups; namely, the nonrelapse group (n = 27) and the relapse group (n = 55), and compared the clinico- pathophysiological characteristics between the two groups. Results. Significantly increased serum immunoglobulin E (IgE) levels (P = 0.0002) and increased frequency of steroid side effects were observed in the relapse group as compared to the nonrelapse group. Conclusions. To develop effective therapeutic modalities, it is important to have a thorough understanding of the clinico-pathophysiological characteristics of MCNS patients showing relapse. © 2007 Japanese Society of Nephrology.

引用

页码：214 / 217

页数：3

共 19 条

[1]

Report of the International Study of Kidney Disease in Children. Minimal change nephrotic syndrome in children: Deaths during the first 5 to 15 years' observation, Pediatrics, 73, pp. 497-501, (1984)

[2]

Coggis C.H., Zurukzoglu W., Minimal change nephrosis in adults, International Congress of Nephrology, pp. 336-44, (1981)

[3]

Lewis E.J., Caeron J.S., Glassock R.J., Management of the nephrotic syndrome in adults, The Nephrotic Syndrome, pp. 461-521, (1988)

[4]

Trompeter R.S., Lloyd B.W., Hicks J., White R.H., Cameron J.S., Long-term outcome for children with minimal-change nephrotic syndrome, Lancet, 1, pp. 368-70, (1985)

[5]

Nolasco F., Cameron J.S., Heywood E.F., Hicks J., Ogg C., Williams D.G., Adult-onset minimal change nephrotic syndrome: A long-term follow-up, Kidney Int, 29, pp. 1215-23, (1986)

[6]

Mak S.K., Short C.D., Mallick N.P., Long-term outcome of adult-onset minimal-change nephropathy, Nephrol Dial Transplant, 11, pp. 2192-201, (1996)

[7]

Shalhoub R.J., Pathogenesis of lipoid nephrosis: A disorder of T-cell function, Lancet, 2, pp. 556-9, (1974)

[8]

Groshong T., Mendelson L., Mendoza S., Bazaral M., Hamburger R., Tune B., Serum IgE in patients with minimal change nephrotic syndrome, J Pediatr, 83, pp. 767-71, (1973)

[9]

Korbet S.M., Schwartz M.M., Lewis E.J., Minimal-change glomerulopathy of adulthood, Am J Nephrol, 8, pp. 291-7, (1988)

[10]

Fujimoto S., Yamamoto Y., Hisanaga S., Morita S., Eto T., Tanaka K., Minimal-change nephrotic syndrome in adult: Response to corticosteroid therapy and frequency of relapse, Am J Kidney Dis, 17, pp. 687-92, (1991)

← 1 2 →